• Adagene Inc.’s $161 million US IPO
• Provident Acquisition Corp.’s $230 million IPO on Nasdaq
• Zai Lab's $766 million Hong Kong secondary listing
• Genetron Holdings Limited’s $256 million US IPO
• InflaRx N.V.’s $100 million US IPO
• CNFinance’s $51.9 million US IPO
• Ingersoll-Rand Global’s $1.15 billion SEC-registered senior notes offering
• Westlake Chemical Corporation’s $500 million SEC-registered notes offering
• iQIYI’s $750 million debut Rule 144A and Reg S convertible notes offering
• Universal American’s $115 million Rule 144A convertible notes offering
• China Orient Asset Management’s $8 billion MTN program update and upsizing and $2 billion investment-grade bonds offering and $700 million investment-grade bonds offering
• 21Vianet Group, Inc.’s $300 million high-yield notes offering and concurrent cash tender offer
• China Oil and Gas Group Limited $320 million high-yield notes offering
• KWG Group Holdings’ $300 million and $350 million high-yield notes offerings

M&A

• “Note: Show Me the Money: Evaluating Personal Jurisdiction over Foreign Nonparty Banks in Light of the Gucci Case,” 49 Cornell Int’l L.J.745 (2016)